Seidman Cancer Center
Showing of 78 results
UH Seidman Cancer Center Researchers Find Real World Data Can Inform Care for Metastatic Castration-Resistant Prostate Cancer
Findings were published in JAMA Network Open.
UH Awarded Once Again for Exceptional Cardiovascular Care of Patients Undergoing Cancer Treatment
International Cardio-Oncology Society grants highest designation.
UH Seidman Cancer Researchers: What is the ideal duration of hormone therapy for the treatment of prostate cancer?
Results published in JAMA Oncology.
University Hospitals Seidman Cancer Center Researchers Develop Easy-to-Use Tool that can Identify High- and Low-Risk Metastatic Prostate Cancer Patients Earlier
Results published in Nature Communications.
What prevents more cancer patients from enrolling in potentially life-saving clinical trials?
Financial barriers are biggest hurdle, according to new Case Western Reserve University and University Hospitals study.
University Hospitals Seidman Cancer Center Researchers Find Age Should Be a Consideration in Metastatic Prostate Cancer Treatment Plans
The study, published in the October 28, 2025 edition of New England Journal of Medicine Evidence, was led by senior author Daniel Spratt, MD.
Randomized Clinical Trial Led by University Hospitals Seidman Cancer Center Oncologist Leads to Practice-Changing Precision Prostate Cancer Therapy
Randomized trial validates first biomarker tool to guide hormone treatment decisions, allowing for more personalized prostate cancer care.
University Hospitals Seidman Cancer Center Named Catalyst Awards Finalist for Excellence in Quality Performance and Measures
Recognized for innovative work improving data integration and enhancing the accuracy and efficiency of tumor registry processes.